For the quarter ending 2026-03-31, OCGN made $1,533,000 in revenue. -$19,177,000 in net income. Net profit margin of -1250.95%.
| Income Statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Total revenue | 1,533,000 | -843,000* | 1,752,000 | - |
| Research and development | 11,255,000 | 36,379,500* | 11,149,000 | - |
| General and administrative | 8,117,000 | 2,895,000* | 8,228,000 | - |
| Total operating expenses | 19,372,000 | 39,274,500* | 19,377,000 | - |
| Loss from operations | -17,839,000 | -40,117,500* | -17,625,000 | - |
| Interest income | 132,000 | 301,000* | 207,000 | - |
| Interest expense | 1,320,000 | 1,246,000* | 1,314,000 | - |
| Other (expense) income, net | -150,000 | 3,293,000* | -1,319,000 | - |
| Total other (expense) income | -1,338,000 | 2,348,000* | -2,426,000 | - |
| Net loss | -19,177,000 | -37,769,500 | -20,051,000 | - |
| Net loss attributable to shareholders - basic | - | -37,769,500 | -20,051,000 | - |
| Net loss attributable to shareholders - basic-Series BPreferred Stock | - | - | 0 | 0 |
| Net loss attributable to shareholders - basic | -19,177,000 | - | - | - |
| Net loss attributable to shareholders - diluted | -19,177,000 | -37,769,500 | -20,051,000 | 0 |
| Basic EPS | -0.06 | -0.126 | -0.07 | 0 |
| Diluted EPS | -0.06 | -0.126 | -0.07 | 0 |
| Basic Average Shares | 327,543,855 | 300,167,989* | 304,003,247 | 0 |
| Diluted Average Shares | 327,543,855 | 300,167,989* | 304,003,247 | 0 |
Ocugen, Inc. (OCGN)
Ocugen, Inc. (OCGN)